From data to discovery: How AI is transforming the drug pipeline

Artificial intelligence (AI) is rapidly transforming the pharmaceutical landscape, fundamentally changing how drugs are discovered, developed and brought to market. Once a niche technology, AI has become a critical enabler of innovation, significantly reducing the time and cost of drug discovery while minimising the risks traditionally associated with the process.

LATEST VIDEO

Latest news

2nd October 2025

Thermo Fisher Scientific to Implement BenchSci AI Technology

2nd October 2025

PROCOS Selected as Speaker at the Italy Pavilion – Expo 2025 Osaka

1st October 2025

OptymEdge hires Senior Director to Drive Global Roll-Out of ACUVERA Platform

1st October 2025

Halozyme to Acquire Elektrofi in $750 Million Deal

1st October 2025

FDA Approves Novartis’ Chronic Spontaneous Urticaria Treatment

1st October 2025

Thermo Fisher Scientific Announces R&D Partnership with AstraZeneca BioVentureHub

1st October 2025

Symeres appoints Gabriella Gentile as Chief Operating Officer to drive transatlantic growth

30th September 2025

NANOFORM EXPANDS COMMERCIAL PRESENCE IN ASIA WITH A&LS PHARMA IN SOUTH KOREA

30th September 2025

Sharp Appoints Samantha Wilson Jones as General Counsel

30th September 2025

Pfizer Strikes Pricing Deal with U.S. Government

29th September 2025

Veranova Appoints Joe Torres-Ocasio as Senior Vice President, Chief Operating Officer

This week’s featured articles

CDMO Partnerships Built on Flexibility, Innovation, Strategic Investment, Sustainability & True End-to-End Support

Large Language Models and Beyond: AI’s Impact on Clinical Trial Efficiency and Integrity

Innovation in mAb purification using affinity chromatography resins based on proprietary rProtein A

Unpacking Global Biopharma Business Relations with Ashu Tandon

A surprising comparison between CDMOs and auto makers

Partnered with top industry events and organisations